5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.79▲ | 1.78▲ | 1.79▲ | 1.78▲ | 1.94▼ |
MA10 | 1.79▼ | 1.79▼ | 1.80▼ | 1.79▼ | 2.05▼ |
MA20 | 1.86▼ | 1.89▼ | 1.98▼ | 1.94▼ | 1.98▼ |
MA50 | 2.09▼ | 2.04▼ | 2.06▼ | 2.07▼ | 2.52▼ |
MA100 | 2.08▼ | 2.10▼ | 2.12▼ | 2.02▼ | N/A |
MA200 | 2.12▼ | 2.00▼ | 2.04▼ | 2.44▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.002▲ | -0.005▼ | -0.017▼ | -0.016▼ | 0.007▲ |
RSI | 35.628▼ | 37.624▼ | 37.684▼ | 42.214▼ | 42.748▼ |
STOCH | 30.998 | 28.307 | 16.507▼ | 31.830 | 28.326 |
WILL %R | -86.047▼ | -86.047▼ | -87.500▼ | -78.261▼ | -83.333▼ |
CCI | -47.743 | -49.859 | -57.182 | -63.343 | -101.320▼ |
MA | $NCI Price Crossed Above MA(7) | Set Alert |
Thursday, August 14, 2025 05:23 AM
Q2 2025 Earnings Call Transcript August 13, 2025 PDS Biotechnology Corporation beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.24. Operator: Greetings. Welcome to PDS ...
|
Tuesday, August 12, 2025 05:25 AM
Endure Biotherapeutics Receives SBIR Phase I Grant to Advance Engineered Native Bacteria Therapy for Familial A ...
|
Wednesday, August 06, 2025 05:37 AM
Q2 2025 Earnings Call Transcript August 5, 2025 Surgery Partners, Inc. beats earnings expectations. Reported EPS is $0.3363, expectations were $0.16. Operator: Good day, and welcome to the Surgery ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 1.77 | 1.81 | 1.66 | 1.79 | 5,100 |
14/08/25 | 1.80 | 1.82 | 1.735 | 1.77 | 13,300 |
13/08/25 | 1.83 | 1.87 | 1.77 | 1.78 | 8,600 |
12/08/25 | 1.732 | 1.84 | 1.72 | 1.84 | 6,600 |
11/08/25 | 1.72 | 1.80 | 1.6951 | 1.71 | 10,956 |
08/08/25 | 1.74 | 1.81 | 1.61 | 1.70 | 39,400 |
07/08/25 | 1.80 | 1.83 | 1.75 | 1.82 | 14,100 |
06/08/25 | 1.852 | 1.8885 | 1.65 | 1.80 | 18,329 |
05/08/25 | 1.852 | 1.92 | 1.80 | 1.84 | 41,252 |
04/08/25 | 1.90 | 1.968 | 1.73 | 1.87 | 91,949 |
|
|
||||
|
|
||||
|
|